| Patent | Date |
|---|
Use of homosalate and octyl salicylate to treat multiple sclerosis
Grant 11,266,664 - DeLuca , et al. March 8, 2 | 2022-03-08 |
Method of treating multiple sclerosis
Grant 11,260,241 - Deluca , et al. March 1, 2 | 2022-03-01 |
Method for treating multiple sclerosis
Grant 10,780,295 - DeLuca , et al. Sept | 2020-09-22 |
Once-a-Week Administration of 25-Hydroxy Vitamin D3 to Sustain Elevated Steady-State Pharmacokinetic Blood Concentration
App 20200281947 - DeLuca; Hector F. ; et al. | 2020-09-10 |
Procedure For Crystallization Of (22e)-(24r)-2-methylene-22-dehydro-1a,24-25-trihydroxy-19-nor-vitamin D3
App 20200262773 - DELUCA; Hector F. ; et al. | 2020-08-20 |
Use Of 2amd And 2md To Treat Fibrosis
App 20200061084 - DeLuca; Hector F. ; et al. | 2020-02-27 |
Method Of Treating Multiple Sclerosis
App 20190381335 - Deluca; Hector F. ; et al. | 2019-12-19 |
Use Of Homosalate And Octyl Salicylate To Treat Multiple Sclerosis
App 20190381075 - DeLuca; Hector F. ; et al. | 2019-12-19 |
(20S)-1-.alpha.,25-dihydroxy-24,24-difluoro-19-nor-vitamin D.sub.3 analogs and their pharmaceutical uses
Grant 10,494,337 - DeLuca , et al. De | 2019-12-03 |
2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
Grant 10,479,764 - DeLuca , et al. Nov | 2019-11-19 |
Use of homosalate and octyl salicylate to treat multiple sclerosis
Grant 10,434,110 - DeLuca , et al. O | 2019-10-08 |
Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
Grant 10,369,161 - DeLuca , et al. | 2019-08-06 |
Method Of Treating Multiple Sclerosis
App 20190009104 - Deluca; Hector F. ; et al. | 2019-01-10 |
Combination of low dose 2-methylene-19-nor-(20S)1.alpha., 25-dihydroxyvitamin D.sub.3 and calcimimetics to treat secondary hyperparathyroidism
Grant 10,105,375 - DeLuca , et al. October 23, 2 | 2018-10-23 |
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-Dihydroxyvitamin D.sub.3 to treat and prevent secondary hyperparathyroidism in a subject having renal failure
Grant 10,046,000 - DeLuca , et al. August 14, 2 | 2018-08-14 |
Combination Of Low Dose 2-methylene-19-nor-(20s)-1alpha, 25-dihydroxyvitamin D3 And Calcimimetics To Treat Secondary Hyperparathyroidism
App 20180055856 - DeLuca; Hector F. ; et al. | 2018-03-01 |
Use Of Homosalate And Octyl Salicylate To Treat Multiple Sclerosis
App 20180015107 - DeLuca; Hector F. ; et al. | 2018-01-18 |
Methods Of Use To Orally And Topically Treat Acne And Other Skin Conditions By Administering A 19-nor Containing Vitamin D Analog With Or Without A Retinoid
App 20170326159 - Clagett-Dame; Margaret ; et al. | 2017-11-16 |
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D.sub.3 and calcimimetics to treat secondary hyperparathyroidism
Grant 9,814,736 - DeLuca , et al. November 14, 2 | 2017-11-14 |
Use Of 2amd And 2md To Treat Fibrosis
App 20170296558 - DeLuca; Hector F. ; et al. | 2017-10-19 |
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism
App 20170252360 - DeLuca; Hector F. ; et al. | 2017-09-07 |
Synthesis And Biological Activity Of 2-methylene Analogs Of Calcitriol And Related Compounds
App 20170253546 - DeLuca; Hector F. ; et al. | 2017-09-07 |
Calcium Formate for Use as a Dietary Supplement
App 20170246206 - DeLuca; Hector F. | 2017-08-31 |
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D3 to prevent secondary hyperparathyroidism or the symptoms thereof
Grant 9,717,744 - DeLuca , et al. August 1, 2 | 2017-08-01 |
Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds
Grant 9,688,596 - DeLuca , et al. June 27, 2 | 2017-06-27 |
Calcium Formate for Use as a Dietary Supplement
App 20170049808 - DeLuca; Hector F. | 2017-02-23 |
Use Of 2-methylene-19-nor-(20s)-1alpha,25-dihydroxyvitamin D3 To Treat Secondary Hyperparathyroidism In Patients Previously Treated With Calcimimetics
App 20170042913 - DeLuca; Hector F. ; et al. | 2017-02-16 |
Synthesis And Biological Activity Of 2-methylene Analogs Of Calcitriol And Related Compounds
App 20170036977 - DeLuca; Hector F. ; et al. | 2017-02-09 |
Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics
Grant 9,539,264 - DeLuca , et al. January 10, 2 | 2017-01-10 |
1-alpha,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 Analogs And Theirpharmaceutical Uses
App 20160347710 - DeLuca; Hector F. ; et al. | 2016-12-01 |
Vitamin D compounds and methods for reducing ocular hypertension (OHT)
Grant 9,452,177 - DeLuca , et al. September 27, 2 | 2016-09-27 |
Methods Of Use To Orally And Topically Treat Acne And Other Skin Conditions By Administering A 19-nor Containing Vitamin D Analog With Or Without A Retinoid
App 20160235770 - Clagett-Dame; Margaret ; et al. | 2016-08-18 |
(22E)-2-methylene-22-dehydro-1.alpha.,24,25-trihydroxy-19-nor-vitamin D.sub.3 analogs
Grant 9,416,102 - DeLuca , et al. August 16, 2 | 2016-08-16 |
Use Of 2-methylene-19-nor-(20s)-1-alpha,25-dihydroxyvitamin D3 To Treat Primary Hyperparathyroidism
App 20160184327 - DeLuca; Hector F. ; et al. | 2016-06-30 |
Use Of 2-methylene-19-nor-(20s)-1-alpha,25-dihydroxyvitamin D3 To Treat Secondary Hyperparathyroidism In Patients Previously Treated With Calcimimetics
App 20160184328 - DeLuca; Hector F. ; et al. | 2016-06-30 |
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism
App 20160136184 - DeLuca; Hector F. ; et al. | 2016-05-19 |
Methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analog with or without a retinoid
Grant 9,339,509 - Clagett-Dame , et al. May 17, 2 | 2016-05-17 |
(20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D.sub.3 analogs and their uses
Grant 9,290,447 - DeLuca , et al. March 22, 2 | 2016-03-22 |
Once-a-Week Administration of 25-Hydroxy Vitamin D3 to Sustain Elevated Steady-State Pharmacokinetic Blood Concentration
App 20150374722 - DeLuca; Hector F. ; et al. | 2015-12-31 |
Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin D.sub.3 and related precursors
Grant 9,212,137 - DeLuca , et al. December 15, 2 | 2015-12-15 |
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to treat secondary hyperparathyroidism
Grant 9,205,096 - DeLuca , et al. December 8, 2 | 2015-12-08 |
Crystallization of (20R) 19-nor-24-difluoro-1.alpha.,25-dihydroxyvitamin D.sub.3
Grant 9,040,728 - DeLuca , et al. May 26, 2 | 2015-05-26 |
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to treat secondary hyperparathyroidism
Grant 9,034,853 - DeLuca , et al. May 19, 2 | 2015-05-19 |
3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses
Grant 8,993,547 - DeLuca , et al. March 31, 2 | 2015-03-31 |
N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses
Grant 8,987,235 - DeLuca , et al. March 24, 2 | 2015-03-24 |
Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1.alpha.,25-dihydroxyvitamin D3
Grant 8,940,916 - DeLuca , et al. January 27, 2 | 2015-01-27 |
Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1.alpha.,25-dihydroxyvitamin D.sub.3
Grant 8,884,039 - DeLuca , et al. November 11, 2 | 2014-11-11 |
(22e)-2-methylene-22-dehydro-1alpha,24,25-trihydroxy-19-nor-vitamin D3 Analogs
App 20140206655 - DeLuca; Hector F. ; et al. | 2014-07-24 |
A-ring modified 19-nor-vitamin D analogs and their uses
Grant 8,785,422 - DeLuca , et al. July 22, 2 | 2014-07-22 |
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism
App 20140187522 - DeLuca; Hector F. ; et al. | 2014-07-03 |
Once-a-week administration of 25-hydroxy vitamin D.sub.3 to sustain elevated steady-state pharmacokinetic blood concentration
Grant 8,759,328 - Deluca , et al. June 24, 2 | 2014-06-24 |
22-haloacetoxy-homopregnacalciferol analogs and their uses
Grant 8,754,067 - DeLuca , et al. June 17, 2 | 2014-06-17 |
Calcium Formate for Use as a Dietary Supplement
App 20140155360 - DeLuca; Hector F. | 2014-06-05 |
3-desoxy-2-methylene-vitamin D analogs and their uses
Grant 8,729,054 - DeLuca , et al. May 20, 2 | 2014-05-20 |
Once-a-week Administration Of 25-hydroxy Vitamin D3 To Sustain Elevated Steady-state Pharmacokinetic Blood Concentration
App 20140100203 - DeLuca; Hector F. ; et al. | 2014-04-10 |
Diastereomers of 2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin D.sub.3
Grant 8,664,206 - DeLuca , et al. March 4, 2 | 2014-03-04 |
1-desoxy-2-methylene-19-nor-vitamin D analogs and their uses
Grant 8,642,579 - DeLuca , et al. February 4, 2 | 2014-02-04 |
Methods Of Use To Orally And Topically Treat Acne And Other Skin Conditions By Administering A 19-nor Containing Vitamin D Analog With Or Without A Retinoid
App 20140018332 - Clagett-Dame; Margaret ; et al. | 2014-01-16 |
2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin D3
App 20140011778 - DeLUCA; Hector F. ; et al. | 2014-01-09 |
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism
App 20140005152 - DeLuca; Hector F. ; et al. | 2014-01-02 |
2.alpha.-methyl and 2.beta.-methyl analogs of 19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and their uses
Grant 8,614,202 - DeLuca , et al. December 24, 2 | 2013-12-24 |
2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs
Grant 8,609,643 - DeLuca , et al. December 17, 2 | 2013-12-17 |
A-Ring Modified 19-Nor-Vitamin D Analogs and Their Uses
App 20130331459 - DeLuca; Hector F. ; et al. | 2013-12-12 |
2-methylene-19,21-dinor-1.alpha.-hydroxy-bishomopregnacalciferol
Grant 8,604,008 - DeLuca , et al. December 10, 2 | 2013-12-10 |
(20S)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-dihydroxyvitamin D.sub.3 and (20R)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-hydroxyvitamin D.sub.3
Grant 8,604,009 - DeLuca , et al. December 10, 2 | 2013-12-10 |
Crystallization of (20R,22R)-2-Methylene-19-Nor-22-Methyl-1alpha,25-Dihydroxyvitamin D3 and Related Precursors
App 20130324752 - DeLuca; Hector F. ; et al. | 2013-12-05 |
Crystallization of (20R)-2-Methylene-19-Nor-24-Difluoro-1alpha,25-Dihydroxyvitamin D3
App 20130324750 - DeLuca; Hector F. ; et al. | 2013-12-05 |
Crystallization of (20R) and (20S) Analogs of 2-Methylene-19-Nor-24-Dimethyl-1alpha,25-Dihydroxyvitamin D3
App 20130324749 - DeLuca; Hector F. ; et al. | 2013-12-05 |
Crystallization of (20R) 19-Nor-24-Difluoro-1alpha,25-Dihydroxyvitamin D3
App 20130324751 - DeLuca; Hector F. ; et al. | 2013-12-05 |
2a-Methyl-19-nor-(20S)-1a,25-dihydroxyvitamin D3 (2AMD) or 2 methylene-19-nor-(20S)-1a,25-dihydroxyvitamin D3 (2MD) Support Survival and Function of Transplanted Islet Cells In Type 1 Diabetes
App 20130295083 - DeLuca; Hector F. ; et al. | 2013-11-07 |
2-methylene-1.alpha.-hydroxy-18,19,21-trinorvitamin D.sub.3 analogs and uses thereof
Grant 8,575,136 - DeLuca , et al. November 5, 2 | 2013-11-05 |
Method for Treating Multiple Sclerosis
App 20130253621 - DeLuca; Hector F. ; et al. | 2013-09-26 |
Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3
Grant 8,519,169 - DeLuca , et al. August 27, 2 | 2013-08-27 |
2-methylene-19-nor-vitamin D analogs and their uses
Grant 8,518,917 - DeLuca , et al. August 27, 2 | 2013-08-27 |
2-Methylene-20(21)-Dehydro-19,24,25,26,27-Pentanor-Vitamin D Analogs
App 20130178449 - DeLuca; Hector F. ; et al. | 2013-07-11 |
2-methylene-vitamin D analogs and their uses
Grant 8,455,467 - DeLuca , et al. June 4, 2 | 2013-06-04 |
(20S,22E)-2-methylene-19-nor-22-ene-1.alpha.,25-dihydroxyvitamin D.sub.3
Grant 8,445,468 - DeLuca , et al. May 21, 2 | 2013-05-21 |
2.alpha.-methyl and 2.beta.-methyl analogs of 19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and their uses
Grant 8,440,647 - DeLuca , et al. May 14, 2 | 2013-05-14 |
3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses
App 20130102567 - DeLuca; Hector F. ; et al. | 2013-04-25 |
2-methylene-vitamin D Analogs And Their Uses
App 20130102574 - DeLuca; Hector F. ; et al. | 2013-04-25 |
2-methylene-vitamin D Analogs And Their Uses
App 20130102573 - DeLuca; Hector F. ; et al. | 2013-04-25 |
Crystallization of 1.alpha.-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol
Grant 8,420,839 - DeLuca , et al. April 16, 2 | 2013-04-16 |
Crystallization of 1alpha-Hydroxy-2-Methylene-18,19-Dinor-Homopregnacalciferol
App 20130090486 - DeLuca; Hector F. ; et al. | 2013-04-11 |
2-methylene-vitamin D analogs and their uses
Grant 8,410,080 - DeLuca , et al. April 2, 2 | 2013-04-02 |
Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
Grant 8,404,667 - Clagett-Dame , et al. March 26, 2 | 2013-03-26 |
2-substituted-1.alpha.,25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof
Grant 8,404,666 - DeLuca , et al. March 26, 2 | 2013-03-26 |
(20R,25S)-2-Methylene-19,26-Dinor-1.alpha.,25-Dihydroxyvitamin D.sub.3 in crystalline form
Grant 8,404,874 - DeLuca , et al. March 26, 2 | 2013-03-26 |
Method Of Treating Multiple Sclerosis
App 20130073009 - Deluca; Hector F. ; et al. | 2013-03-21 |
2.alpha.-methyl-19-nor-1.alpha.-hydroxy-homopregnacalciferol and its uses
Grant 8,399,438 - DeLuca , et al. March 19, 2 | 2013-03-19 |
2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
Grant 8,399,439 - DeLuca , et al. March 19, 2 | 2013-03-19 |
Crystallization of 1alpha-Hydroxy-20-Methyl-2-Methylene-19,24,25,26,27-Pentanorvitamin D3
App 20130053587 - DeLuca; Hector F. ; et al. | 2013-02-28 |
2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin D3
App 20130053356 - DELUCA; Hector F. ; et al. | 2013-02-28 |
2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses
App 20130018021 - DeLuca; Hector F. ; et al. | 2013-01-17 |
Method of preventing Type 1 diabetes
Grant 8,349,818 - DeLuca , et al. January 8, 2 | 2013-01-08 |
2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs
App 20130005686 - DeLuca; Hector F. ; et al. | 2013-01-03 |
3-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
App 20120322775 - DeLuca; Hector F. ; et al. | 2012-12-20 |
(20S)-24-(p-Toluenesulfonyloxy)-25,26,27-Trinorvitamin D3 Analogs and Their Uses
App 20120283227 - DeLuca; Hector F. ; et al. | 2012-11-08 |
2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses
App 20120283228 - DeLuca; Hector F. ; et al. | 2012-11-08 |
17,20(Z)-dehydro vitamin D analogs and their uses
Grant 8,232,263 - DeLuca , et al. July 31, 2 | 2012-07-31 |
2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
Grant 8,222,236 - DeLuca , et al. July 17, 2 | 2012-07-17 |
2-methylene-19-nor-(20R)-1.alpha.-hydroxy-bishomopregnacalciferol
Grant 8,222,235 - DeLuca , et al. July 17, 2 | 2012-07-17 |
19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring
Grant 8,217,023 - DeLuca , et al. July 10, 2 | 2012-07-10 |
Diastereomers Of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin D3
App 20120165300 - DeLUCA; Hector F. ; et al. | 2012-06-28 |
2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
App 20120157418 - DeLuca; Hector F. ; et al. | 2012-06-21 |
22-Haloacetoxy-Homopregnacalciferol Analogs and Their Uses
App 20120149669 - DeLuca; Hector F. ; et al. | 2012-06-14 |
13,13-dimethyl-des-C,D analogs of 1.alpha.,25-dihydroxy-19-nor-vitamin D.sub.3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
Grant 8,193,171 - DeLuca , et al. June 5, 2 | 2012-06-05 |
2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
Grant 8,193,170 - DeLuca , et al. June 5, 2 | 2012-06-05 |
(20R)-2.alpha.-methyl-19,26,2-trinor-vitamin D analogs
Grant 8,193,169 - DeLuca , et al. June 5, 2 | 2012-06-05 |
Vitamin D analogs for obesity prevention and treatment
Grant 8,188,064 - Clagett-Dame , et al. May 29, 2 | 2012-05-29 |
6-methylvitamin D.sub.3 analogs and their uses
Grant 8,178,517 - DeLuca , et al. May 15, 2 | 2012-05-15 |
Methods and compositions for phosphate binding
Grant 8,158,117 - DeLuca , et al. April 17, 2 | 2012-04-17 |
(20R,25S)-2-Methylene-19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 in Crystalline Form
App 20120083614 - DeLuca; Hector F. ; et al. | 2012-04-05 |
Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin D compound
Grant 8,143,238 - DeLuca , et al. March 27, 2 | 2012-03-27 |
2alpha-Methyl-19-Nor-(20S)-1alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
App 20120071562 - DeLuca; Hector F. ; et al. | 2012-03-22 |
Calcium Formate for Use as a Dietary Supplement
App 20120046252 - DeLuca; Hector F. | 2012-02-23 |
Methods and compositions for phosphate binding
Grant 8,114,393 - DeLuca , et al. February 14, 2 | 2012-02-14 |
2-methylene-(20S,25S)-19,27-dinor-(22E)-vitamin D analogs
Grant 8,114,859 - DeLuca , et al. February 14, 2 | 2012-02-14 |
2.alpha.-methyl-19-nor-(20S)-1.alpha.-hydroxy-bishomopregnacalciferol and its uses
Grant 8,093,232 - DeLuca , et al. January 10, 2 | 2012-01-10 |
2-METHYLENE-19,26-NOR-(20S)-1alpha-HYDROXYVITAMIN D3
App 20110294764 - DeLuca; Hector F. ; et al. | 2011-12-01 |
1a-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof
Grant 8,058,265 - Deluca , et al. November 15, 2 | 2011-11-15 |
19,26,27-trinor-1.alpha.,25-dihydroxyvitamin D.sub.3 compounds
Grant 8,030,295 - DeLuca , et al. October 4, 2 | 2011-10-04 |
(20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3
App 20110237556 - DeLuca; Hector F. ; et al. | 2011-09-29 |
Diastereomers Of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin D3
App 20110237557 - DeLuca; Hector F. ; et al. | 2011-09-29 |
Methods of Use To Orally and Topically Treat Acne and Other Skin Conditions By Administering a 19-NOR Containing Vitamin D Analog With or Without a Retinoid
App 20110195941 - Clagett-Dame; Margaret ; et al. | 2011-08-11 |
Modified retinoid compounds and their uses
Grant 7,964,639 - DeLuca , et al. June 21, 2 | 2011-06-21 |
Method of Preventing Type I Diabetes
App 20110124609 - DeLuca; Hector F. ; et al. | 2011-05-26 |
2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs
Grant 7,947,666 - DeLuca , et al. May 24, 2 | 2011-05-24 |
2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs
Grant 7,943,601 - DeLuca , et al. May 17, 2 | 2011-05-17 |
Use of Carbon-2-Modified-Vitamin D Analogs to Induce the Formation of New Bone
App 20110112056 - DeLuca; Hector F. ; et al. | 2011-05-12 |
Once-a-week Administration Of 25-hydroxy Vitamin D3 To Sustain Elevated Steady-state Pharmacokinetic Blood Concentration
App 20110105444 - Deluca; Hector F. ; et al. | 2011-05-05 |
(20S,22E)-2-Methylene-19-Nor-22-Ene-1Alpha,25-Dihydroxyvitamin D3
App 20110086824 - DeLuca; Hector F. ; et al. | 2011-04-14 |
6-Methylvitamin D3 Analogs and Their Uses
App 20110082123 - DeLuca; Hector F. ; et al. | 2011-04-07 |
1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
App 20110082121 - DeLuca; Hector F. ; et al. | 2011-04-07 |
19-Nor-Vitamin D Analogs With 1,2- or 3,2-Cyclopentene Ring
App 20110082122 - DeLuca; Hector F. ; et al. | 2011-04-07 |
Vitamin D receptor antagonists and their use in treating asthma
Grant 7,915,242 - DeLuca , et al. March 29, 2 | 2011-03-29 |
Calcium Formate For Use As A Dietary Supplement
App 20110059927 - DeLuca; Hector F. | 2011-03-10 |
Vitamin D Compounds and Methods for Reducing Ocular Hypertension (OHT)
App 20110059926 - DeLuca; Hector F. ; et al. | 2011-03-10 |
2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
Grant 7,893,043 - DeLuca , et al. February 22, 2 | 2011-02-22 |
2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
Grant 7,888,339 - DeLuca , et al. February 15, 2 | 2011-02-15 |
Method of Preventing Renal Disease and Treating Symptoms Thereof
App 20110034426 - DeLuca; Hector F. ; et al. | 2011-02-10 |
19-nor-vitamin D analogs with 1,2-dihydrofuran ring
Grant 7,879,829 - DeLuca , et al. February 1, 2 | 2011-02-01 |
All-trans Retinoid Esters As Active Pharmaceutical Ingredients, Oral And Topical Dosage Form Compositions Thereof, And Methods Of Treating Skin Conditions Thereof
App 20110003892 - Clagett-Dame; Margaret ; et al. | 2011-01-06 |
Calcium formate for use as a dietary supplement
Grant 7,850,991 - DeLuca December 14, 2 | 2010-12-14 |
Vitamin D analog--RAK, methods and uses thereof
Grant 7,803,789 - Deluca , et al. September 28, 2 | 2010-09-28 |
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
Grant RE41,491 - DeLuca , et al. August 10, 2 | 2010-08-10 |
(20S)-1.alpha.-Hydroxy-2-Methylene-19-Nor-Bishomopregnacalciferol and its uses
Grant RE41,474 - DeLuca , et al. August 3, 2 | 2010-08-03 |
1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain
Grant 7,763,598 - DeLuca , et al. July 27, 2 | 2010-07-27 |
Modified retinoid compounds and their uses
Grant 7,763,599 - DeLuca , et al. July 27, 2 | 2010-07-27 |
2-Alkylidene-18,19-Dinor-Vitamin D Compounds
App 20100179344 - DeLuca; Hector F. ; et al. | 2010-07-15 |
Modified retinoid compounds and their uses
Grant 7,750,043 - DeLuca , et al. July 6, 2 | 2010-07-06 |
Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
Grant 7,745,404 - DeLuca , et al. June 29, 2 | 2010-06-29 |
Treatment of Inflammatory Bowel Disease With 2-Methylene-19-Nor-Vitamin D Compounds
App 20100160267 - DeLuca; Hector F. ; et al. | 2010-06-24 |
2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs
Grant 7,741,314 - DeLuca , et al. June 22, 2 | 2010-06-22 |
17,20(E)-dehydro vitamin D analogs and their uses
Grant 7,741,313 - DeLuca , et al. June 22, 2 | 2010-06-22 |
(20S)-23,23-difluoro-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs
Grant 7,718,637 - DeLuca , et al. May 18, 2 | 2010-05-18 |
Use of 2-methylene-19-nor-20(S)-1alpha,25dihydroxy vitamin d3 to inhibit mammary tumor
Grant 7,718,636 - DeLuca , et al. May 18, 2 | 2010-05-18 |
(20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs
Grant 7,718,638 - DeLuca , et al. May 18, 2 | 2010-05-18 |
2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vit- amin D analogs
Grant 7,713,953 - DeLuca , et al. May 11, 2 | 2010-05-11 |
2-alkylidene-18,19-dinor-vitamin D compounds
Grant 7,713,951 - DeLuca , et al. May 11, 2 | 2010-05-11 |
2-methylene-19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D3 and its uses
Grant 7,713,952 - DeLuca , et al. May 11, 2 | 2010-05-11 |
Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
Grant 7,704,980 - DeLuca , et al. April 27, 2 | 2010-04-27 |
2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses
Grant 7,704,982 - DeLuca , et al. April 27, 2 | 2010-04-27 |
2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin D3 and uses thereof
Grant 7,704,981 - DeLuca , et al. April 27, 2 | 2010-04-27 |
2-methylene-1.alpha.-hydroxy-19,21-dinorvitamin D.sub.3 analogs and uses thereof
Grant 7,648,972 - DeLuca , et al. January 19, 2 | 2010-01-19 |
2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin D.sub.3 analogs and uses thereof
Grant 7,648,973 - DeLuca , et al. January 19, 2 | 2010-01-19 |
19-nor-vitamin D analogs with 3,2-dihydrofuran ring
Grant 7,648,974 - DeLuca , et al. January 19, 2 | 2010-01-19 |
19-nor-vitamin D Analogs With 3,2-dihydrofuran Ring
App 20100009945 - DeLuca; Hector F. ; et al. | 2010-01-14 |
2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs
App 20100009940 - DeLuca; Hector F. ; et al. | 2010-01-14 |
2-Methylene-(22E)-25-(1-Methylene-Hexyl)-26,27-Cyclo-22-Dehydro-19-Nor-Vit- amin D Analogs
App 20100009943 - DeLuca; Hector F. ; et al. | 2010-01-14 |
19-Nor-Vitamin D Analogs with 1,2-Dihydrofuran Ring
App 20100009944 - DeLuca; Hector F. ; et al. | 2010-01-14 |
2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs
App 20100009947 - DeLuca; Hector F. ; et al. | 2010-01-14 |
2-Methylene-(17Z)-17(20)-Dehydro-19,21-Dinor-Vitamin D Analogs
App 20100009942 - DeLuca; Hector F. ; et al. | 2010-01-14 |
2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs
App 20100009941 - DeLuca; Hector F. ; et al. | 2010-01-14 |
2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs
App 20100009946 - DeLuca; Hector F. ; et al. | 2010-01-14 |
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D Compounds And Methods Of Making And Treatment Thereof
App 20090281340 - DeLuca; Hector F. ; et al. | 2009-11-12 |
Methods Of Increasing Epidermal Skin Thickness By Topical Administration Of A 19-nor Containing Vitamin D Compound
App 20090227545 - DeLuca; Hector F. ; et al. | 2009-09-10 |
Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
Grant 7,566,696 - DeLuca , et al. July 28, 2 | 2009-07-28 |
13,13-Dimethyl-des-C,D Analogs of 1Alpha,25-Dihydroxy-19-Nor-Vitamin D3 Compounds and Topical Composition Dosage Forms and Methods of Treating Skin Conditions Thereof
App 20090186950 - DeLuca; Hector F. ; et al. | 2009-07-23 |
2-methylene-19-nor-(20S-24S)-1.alpha.,25-dihydroxyvitamin-D.sub.2
Grant 7,563,783 - DeLuca , et al. July 21, 2 | 2009-07-21 |
(20S)-23,23-Difluoro-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs
App 20090170818 - DeLuca; Hector F. ; et al. | 2009-07-02 |
2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs
App 20090170821 - DeLuca; Hector F. ; et al. | 2009-07-02 |
2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs
App 20090170822 - DeLuca; Hector F. ; et al. | 2009-07-02 |
2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs
App 20090170820 - DeLuca; Hector F. ; et al. | 2009-07-02 |
(20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs
App 20090170819 - DeLuca; Hector F. ; et al. | 2009-07-02 |
26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
App 20090143342 - DeLuca; Hector F. ; et al. | 2009-06-04 |
2-methylene-19-nor-(20S)-1.alpha.-hydroxy-trishomopregnacalciferol
Grant 7,541,348 - DeLuca , et al. June 2, 2 | 2009-06-02 |
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone
Grant 7,541,349 - DeLuca , et al. June 2, 2 | 2009-06-02 |
19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring
Grant 7,538,098 - DeLuca , et al. May 26, 2 | 2009-05-26 |
Des-C,D analogs of 1.alpha.,25-dihydroxy-19-norvitamin D.sub.3
Grant 7,534,777 - DeLuca , et al. May 19, 2 | 2009-05-19 |
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
Grant 7,534,778 - DeLuca , et al. May 19, 2 | 2009-05-19 |
2-Propylidene-19-nor-vitamin D compounds
Grant 7,531,527 - DeLuca , et al. May 12, 2 | 2009-05-12 |
Vitamin D analog--NEL, methods and uses thereof
Grant 7,528,122 - DeLuca , et al. May 5, 2 | 2009-05-05 |
2-methylene-19-nor-(20S-24epi)-1.alpha.,25-dihydroxyvitamin D.sub.2
Grant 7,511,030 - DeLuca , et al. March 31, 2 | 2009-03-31 |
Methods and compositions for phosphate binding
App 20090004133 - DeLuca; Hector F. ; et al. | 2009-01-01 |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
Grant 7,468,361 - DeLuca , et al. December 23, 2 | 2008-12-23 |
(20R)-2a-Methyl-19,26,27-Trinor-Vitamin D Analogs
App 20080300223 - DeLuca; Hector F. ; et al. | 2008-12-04 |
Compounds, Compositions, Kits And Methods Of Use To Orally And Topically Treat Acne And Other Skin Conditions By Administering A 19-nor Containing Vitamin D Analog With Or Without A Retinoid
App 20080261925 - Clagett-Dame; Margaret ; et al. | 2008-10-23 |
Method of Extending the Dose Range of Vitamin D Compounds
App 20080249068 - DeLuca; Hector F. ; et al. | 2008-10-09 |
Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders
Grant 7,419,992 - DeLuca , et al. September 2, 2 | 2008-09-02 |
Modified Retinoid Compounds and Their Uses
App 20080194534 - DeLuca; Hector F. ; et al. | 2008-08-14 |
Modified Retinoid Compounds and Their Uses
App 20080188559 - DeLuca; Hector F. ; et al. | 2008-08-07 |
Use Of Calcitonin And Calcitonin-like Peptides To Treat And Prevent Multiple Sclerosis
App 20080146491 - DeLuca; Hector F. ; et al. | 2008-06-19 |
(20S)-1Alpha-Hydroxy-2-Methylene-19-Nor-Bishomopregnacalciferol and Its Uses
App 20080096851 - DeLuca; Hector F. ; et al. | 2008-04-24 |
2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs
App 20080081800 - DeLuca; Hector F. ; et al. | 2008-04-03 |
2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs
App 20080081799 - DeLuca; Hector F. ; et al. | 2008-04-03 |
2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds
App 20080032956 - DeLuca; Hector F. ; et al. | 2008-02-07 |
Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin
App 20080031957 - DeLuca; Hector F. ; et al. | 2008-02-07 |
Vitamin D Compounds Used To Stabilize Kidney Transplants
App 20080021002 - DeLuca; Hector F. ; et al. | 2008-01-24 |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
Grant 7,300,925 - DeLuca , et al. November 27, 2 | 2007-11-27 |
2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses
App 20070270391 - DeLuca; Hector F. ; et al. | 2007-11-22 |
2-methylene-19-nor-(23s)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone And 2-methylene-19-nor-(23r)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone
App 20070259953 - DeLuca; Hector F. ; et al. | 2007-11-08 |
17,20(Z)-Dehydro Vitamin D Analogs and Their Uses
App 20070259838 - DeLuca; Hector F. ; et al. | 2007-11-08 |
2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
App 20070254857 - DeLuca; Hector F. ; et al. | 2007-11-01 |
2-Methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses
App 20070249569 - DeLuca; Hector F. ; et al. | 2007-10-25 |
17,20(E)-dehydro vitamin D analogs and their uses
App 20070249568 - DeLuca; Hector F. ; et al. | 2007-10-25 |
2-Methylene-19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Its Uses
App 20070249567 - DeLuca; Hector F. ; et al. | 2007-10-25 |
1a-Hydroxy-2-(3'-Hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof
App 20070244072 - Deluca; Hector F. ; et al. | 2007-10-18 |
2-Methylene-1Alpha,25-Dihydroxy-18,19,21-Trinorvitamin D3 and Uses Thereof
App 20070238705 - DeLuca; Hector F. ; et al. | 2007-10-11 |
1alpha-Hydroxy-2-(3'-Hydroxypropylidene)-19-Nor-Vitamin D Compounds with a 1,1-Dimethylpropyl Side Chain
App 20070238703 - DeLuca; Hector F. ; et al. | 2007-10-11 |
19-Nor-Vitamin D Analogs with 1,2 or 3,2 Heterocyclic Ring
App 20070238712 - DeLuca; Hector F. ; et al. | 2007-10-11 |
2-Methylene-1Alpha-Hydroxy-19,21-Dinorvitamin D3 Analogs and Uses Thereof
App 20070238702 - DeLuca; Hector F. ; et al. | 2007-10-11 |
2-Substituted-1Alpha,25-Dihydroxy-19,26,27-Trinor Vitamin D Analogs and Uses Thereof
App 20070238704 - DeLuca; Hector F. ; et al. | 2007-10-11 |
2-Methylene-1alpha-Hydroxy-18,19,21-Trinorvitamin D3 Analogs and Uses Thereof
App 20070238701 - DeLuca; Hector F. ; et al. | 2007-10-11 |
2-Methylene-1Alpha,25-Dihydroxy-19,21-Dinorvitamin D3 Analogs and Uses Thereof
App 20070238706 - DeLuca; Hector F. ; et al. | 2007-10-11 |
19,26,27-TRINOR-1alpha,25-DIHYDROXYVITAMIN D3 COMPOUNDS
App 20070219168 - DeLuca; Hector F. ; et al. | 2007-09-20 |
2-Propylidene-19-nor-vitamin D compounds
App 20070213546 - DeLuca; Hector F. ; et al. | 2007-09-13 |
Method of extending the dose range of vitamin D compounds
Grant 7,259,143 - DeLuca , et al. August 21, 2 | 2007-08-21 |
Vitamin D Analog - Rak, Methods And Uses Thereof
App 20070191317 - DELUCA; Hector F. ; et al. | 2007-08-16 |
Vitamin D Analog - Nel, Methods And Uses Thereof
App 20070191316 - DELUCA; Hector F. ; et al. | 2007-08-16 |
2-methylene-19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and its uses
Grant 7,244,719 - DeLuca , et al. July 17, 2 | 2007-07-17 |
2-propylidene-19-nor-vitamin D compounds
Grant 7,241,747 - DeLuca , et al. July 10, 2 | 2007-07-10 |
Synthesis of indole thiazole compounds as ligands for the Ah receptor
Grant 7,241,900 - DeLuca , et al. July 10, 2 | 2007-07-10 |
19,26,27-trinor-1.alpha.,25-dihydroxyvitamin D.sub.3 compounds
Grant 7,241,909 - DeLuca , et al. July 10, 2 | 2007-07-10 |
17,20(Z)-dehydro vitamin D analogs and their uses
Grant 7,241,748 - DeLuca , et al. July 10, 2 | 2007-07-10 |
2.alpha.-Methyl and 2.beta.-methyl analogs of 19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and their uses
Grant 7,241,749 - DeLuca , et al. July 10, 2 | 2007-07-10 |
17,20(E)-dehydro vitamin D analogs and their uses
Grant 7,241,752 - DeLuca , et al. July 10, 2 | 2007-07-10 |
2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses
Grant 7,241,750 - DeLuca , et al. July 10, 2 | 2007-07-10 |
2.alpha.-methyl-19-nor-(20S)-1.alpha.-hydroxy-bishomopregnacalciferol and its uses
Grant 7,241,751 - DeLuca , et al. July 10, 2 | 2007-07-10 |
2-Methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses
Grant 7,238,681 - DeLuca , et al. July 3, 2 | 2007-07-03 |
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone
Grant 7,235,680 - DeLuca , et al. June 26, 2 | 2007-06-26 |
2-methylene-19-nor-vitamin D2 compounds
Grant 7,232,810 - DeLuca , et al. June 19, 2 | 2007-06-19 |
Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3
App 20070112077 - DeLuca; Hector F. ; et al. | 2007-05-17 |
Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
App 20070105774 - DeLuca; Hector F. ; et al. | 2007-05-10 |
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 for the prophylaxis of bone diseases
Grant 7,214,671 - DeLuca , et al. May 8, 2 | 2007-05-08 |
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to increase the life expectancy of human beings
Grant 7,214,670 - DeLuca , et al. May 8, 2 | 2007-05-08 |
Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol
Grant 7,208,484 - DeLuca , et al. April 24, 2 | 2007-04-24 |
2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds
App 20070088008 - DeLuca; Hector F. ; et al. | 2007-04-19 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D.sub.3 and their uses
Grant 7,205,286 - DeLuca , et al. April 17, 2 | 2007-04-17 |
Methods and compositions for phosphate binding
App 20070071715 - DeLuca; Hector F. ; et al. | 2007-03-29 |
19,23,24,25,26,27-Hexanor-1alpha-hydroxyvitamin D3
App 20070066566 - DeLuca; Hector F. ; et al. | 2007-03-22 |
Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders
App 20070043092 - DeLuca; Hector F. ; et al. | 2007-02-22 |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
Grant 7,141,558 - DeLuca , et al. November 28, 2 | 2006-11-28 |
19,26,27-trinor-1alpha,25-dihydroxyvitamin D3 compounds
App 20060264410 - DeLuca; Hector F. ; et al. | 2006-11-23 |
Use of 2-methylene-19-nor-20(S)-1alpha,25dihydroxyvitamin D3 to increase the life expectancy of human beings
App 20060241090 - DeLuca; Hector F. ; et al. | 2006-10-26 |
Method of reducing toxicity of retinoids
Grant 7,126,017 - DeLuca , et al. October 24, 2 | 2006-10-24 |
2-Methylene-19-nor-(23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone
App 20060223782 - DeLuca; Hector F. ; et al. | 2006-10-05 |
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to increase bone strength
Grant 7,115,594 - DeLuca , et al. October 3, 2 | 2006-10-03 |
26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds
Grant 7,112,579 - DeLuca , et al. September 26, 2 | 2006-09-26 |
Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
App 20060189532 - DeLuca; Hector F. ; et al. | 2006-08-24 |
Method of locking 1.alpha.-OH of vitamin D compounds in axial orientation
Grant 7,094,776 - DeLuca , et al. August 22, 2 | 2006-08-22 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D.sub.3 and their uses
Grant 7,094,916 - DeLuca , et al. August 22, 2 | 2006-08-22 |
26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds
Grant 7,094,774 - DeLuca , et al. August 22, 2 | 2006-08-22 |
2-Methylene-19-nor-(20S-24epi)-1alpha,25-dihydroxyvitamin D2
App 20060183721 - DeLuca; Hector F. ; et al. | 2006-08-17 |
2-Methylene-19-nor-(20S-24S)-1alpha,25-dihydroxyvitamin D2
App 20060183716 - DeLuca; Hector F. ; et al. | 2006-08-17 |
2alpha-methyl-19-nor-(20S)-1alpha-hydroxy-bishomopregnacalciferol and its uses
App 20060160769 - DeLuca; Hector F. ; et al. | 2006-07-20 |
(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20060148769 - DeLuca; Hector F. ; et al. | 2006-07-06 |
2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
App 20060148759 - DeLuca; Hector F. ; et al. | 2006-07-06 |
Method of locking 1.alpha.-OH of vitamin D compounds in axial orientation
Grant 7,071,179 - DeLuca , et al. July 4, 2 | 2006-07-04 |
2-Methylene-19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and its uses
App 20060142246 - DeLuca; Hector F. ; et al. | 2006-06-29 |
2-Methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol
App 20060135798 - DeLuca; Hector F. ; et al. | 2006-06-22 |
Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
App 20060135492 - DeLuca; Hector F. ; et al. | 2006-06-22 |
2-Methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol
App 20060135800 - DeLuca; Hector F. ; et al. | 2006-06-22 |
Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
App 20060135493 - DeLuca; Hector F. ; et al. | 2006-06-22 |
2-Methylene-19-NOR-(20R)-1alpha-hydroxy-bishomopregnacalciferol
App 20060135799 - DeLuca; Hector F. ; et al. | 2006-06-22 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D.sub.3 and their uses
Grant 7,064,115 - DeLuca , et al. June 20, 2 | 2006-06-20 |
2-Methylene-18,19-dinor-1alpha-hydroxy-homopregnacalciferol and its uses
App 20060122157 - DeLuca; Hector F. ; et al. | 2006-06-08 |
Method of locking 1.alpha.-OH of vitamin D compounds in axial orientation
Grant 7,056,904 - DeLuca , et al. June 6, 2 | 2006-06-06 |
17,20(Z)-dehydro vitamin D analogs and their uses
App 20060116351 - DeLuca; Hector F. ; et al. | 2006-06-01 |
2alpha-Methyl and 2beta-methyl analogs of 19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and their uses
App 20060116352 - DeLuca; Hector F. ; et al. | 2006-06-01 |
Methods for reducing body fat using vitamin D compounds
Grant 7,053,075 - DeLuca , et al. May 30, 2 | 2006-05-30 |
2-Methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses
App 20060111321 - DeLuca; Hector F. ; et al. | 2006-05-25 |
17,20(E)-dehydro vitamin D analogs and their uses
App 20060111330 - DeLuca; Hector F. ; et al. | 2006-05-25 |
Method of treatment of type I diabetes
App 20060079490 - DeLuca; Hector F. ; et al. | 2006-04-13 |
Synthesis of indole thiazole compounds as ligands for the Ah receptor
App 20060079692 - DeLuca; Hector F. ; et al. | 2006-04-13 |
Synthesis of indole thiazole compounds as ligands for the Ah receptor
Grant 7,002,019 - DeLuca , et al. February 21, 2 | 2006-02-21 |
2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds
Grant 6,992,074 - DeLuca , et al. January 31, 2 | 2006-01-31 |
Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
App 20060003973 - DeLuca; Hector F. ; et al. | 2006-01-05 |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
App 20050282789 - DeLuca, Hector F. ; et al. | 2005-12-22 |
2-alkylidene-18,19-dinor-vitamin D compounds
App 20050227950 - DeLuca, Hector F. ; et al. | 2005-10-13 |
Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone
App 20050203071 - Deluca, Hector F ; et al. | 2005-09-15 |
Use of 2.alpha.-methly-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D3 to increase bone strength
Grant 6,939,868 - DeLuca , et al. September 6, 2 | 2005-09-06 |
Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
App 20050187201 - DeLuca, Hector F. ; et al. | 2005-08-25 |
Method of locking 1alpha-OH of vitamin D compounds in axial orientation
App 20050182034 - DeLuca, Hector F. ; et al. | 2005-08-18 |
Method of locking 1beta-OH of vitamin D compounds in axial orientation
App 20050182035 - DeLuca, Hector F. ; et al. | 2005-08-18 |
Vitamin D receptor antagonists and their use in treating asthma
App 20050182033 - DeLuca, Hector F. ; et al. | 2005-08-18 |
Method of locking 1alpha-OH of vitamin D compounds in axial orientation
App 20050164995 - DeLuca, Hector F. ; et al. | 2005-07-28 |
(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20050159397 - DeLuca, Hector F. ; et al. | 2005-07-21 |
Preparations and use of an Ah receptor ligand, 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
Grant 6,916,834 - DeLuca , et al. July 12, 2 | 2005-07-12 |
Methods for reducing body fat using vitamin D compounds
App 20050143358 - DeLuca, Hector F. ; et al. | 2005-06-30 |
Vitamin D analogs for obesity prevention and treatment
App 20050119242 - DeLuca, Hector F. ; et al. | 2005-06-02 |
Calcium formate for use as a dietary supplement
App 20050106234 - DeLuca, Hector F. | 2005-05-19 |
2-methylene-19-nor-20(S)-25-methyl-1.alpha.-hydroxycalciferol and its uses
Grant 6,894,037 - DeLuca , et al. May 17, 2 | 2005-05-17 |
Method of locking 1.alpha.-OH of vitamin D compounds in axial orientation
Grant 6,890,914 - DeLuca , et al. May 10, 2 | 2005-05-10 |
(20S)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
App 20050096300 - DeLuca, Hector F. ; et al. | 2005-05-05 |
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
Grant 6,887,860 - DeLuca , et al. May 3, 2 | 2005-05-03 |
Method of reducing toxicity of retinoids
App 20050085539 - DeLuca, Hector F. ; et al. | 2005-04-21 |
Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
App 20050080059 - DeLuca, Hector F. ; et al. | 2005-04-14 |
2-methylene-19-nor-vitamin D2 compounds
App 20050070511 - DeLuca, Hector F. ; et al. | 2005-03-31 |
Use of 2-Methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase the life expectancy of human beings
App 20050065123 - DeLuca, Hector F. ; et al. | 2005-03-24 |
2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds
App 20050043281 - DeLuca, Hector F. ; et al. | 2005-02-24 |
(20S) 1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D3 and their uses
Grant 6,846,811 - DeLuca , et al. January 25, 2 | 2005-01-25 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-NOR-vitamin D3 and their uses
Grant 6,844,330 - DeLuca , et al. January 18, 2 | 2005-01-18 |
Synthesis of A-ring synthon of 19-NOR-1.alpha.,25-dihydroxyvitamin D3 from (D)-glucose
Grant 6,844,461 - DeLuca , et al. January 18, 2 | 2005-01-18 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D3 and their uses
Grant 6,844,332 - DeLuca , et al. January 18, 2 | 2005-01-18 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D3 and their uses
Grant 6,844,457 - DeLuca , et al. January 18, 2 | 2005-01-18 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D3 and their uses
Grant 6,844,331 - DeLuca , et al. January 18, 2 | 2005-01-18 |
(20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
App 20050009792 - DeLuca, Hector F. ; et al. | 2005-01-13 |
2-Methylene-19-nor-20(S)-25-methyl-1alpha-hydroxycalciferol and its uses
App 20050004085 - DeLuca, Hector F. ; et al. | 2005-01-06 |
2-methylene-19-nor-20(S)-1.alpha.-hydroxy-bis-homo-pregnacalciferol in crystalline form
Grant 6,835,723 - DeLuca , et al. December 28, 2 | 2004-12-28 |
2-Propylidene-19-nor-vitamin D compounds
App 20040229851 - DeLuca, Hector F. ; et al. | 2004-11-18 |
Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalcife- rol
App 20040220418 - DeLuca, Hector F. ; et al. | 2004-11-04 |
2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
Grant 6,806,262 - DeLuca , et al. October 19, 2 | 2004-10-19 |
Synthesis of indole thiazole compounds as ligands for the Ah receptor
App 20040204588 - DeLuca, Hector F. ; et al. | 2004-10-14 |
Modified retinoid compounds and their uses
App 20040167215 - DeLuca, Hector F. ; et al. | 2004-08-26 |
26,27-Homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds
App 20040167104 - DeLuca, Hector F. ; et al. | 2004-08-26 |
Method of synthesizing 1.alpha.-hydroxy-2-methylene-19-nor-homopregnacalciferol
Grant 6,774,251 - DeLuca , et al. August 10, 2 | 2004-08-10 |
(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20040152678 - DeLuca, Hector F. ; et al. | 2004-08-05 |
(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20040152680 - DeLuca, Hector F. ; et al. | 2004-08-05 |
(20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20040152677 - DeLuca, Hector F. ; et al. | 2004-08-05 |
(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20040152675 - DeLuca, Hector F. ; et al. | 2004-08-05 |
(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20040152679 - DeLuca, Hector F. ; et al. | 2004-08-05 |
(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20040152676 - DeLuca, Hector F. ; et al. | 2004-08-05 |
Treatment of systemic lupus erythematosis
App 20040142912 - DeLuca, Hector F. ; et al. | 2004-07-22 |
Synthesis of a-ring synthon of 19-nor-1alpha,25-dihydroxyvitamin D3 from (D)-glucose
App 20040133026 - DeLuca, Hector F. ; et al. | 2004-07-08 |
26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds
App 20040082802 - DeLuca, Hector F. ; et al. | 2004-04-29 |
Use of 2alpha-methly-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
App 20040072804 - DeLuca, Hector F. ; et al. | 2004-04-15 |
Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
App 20040068129 - DeLuca, Hector F. ; et al. | 2004-04-08 |
Method of extending the dose range of vitamin D compounds
App 20040053813 - DeLuca, Hector F. ; et al. | 2004-03-18 |
26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
Grant 6,696,431 - DeLuca , et al. February 24, 2 | 2004-02-24 |
(20S)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
App 20040033998 - DeLuca, Hector F. ; et al. | 2004-02-19 |
Calcium formate for use as a dietary supplement
App 20040029964 - DeLuca, Hector F. | 2004-02-12 |
Synthesis of A-ring synthon of 19-nor-1.alpha.,25-dihydroxyvitamin D3 from (D)-glucose
Grant 6,683,219 - DeLuca , et al. January 27, 2 | 2004-01-27 |
Treatment of systemic lupus erythematosis
Grant 6,673,782 - DeLuca , et al. January 6, 2 | 2004-01-06 |
26,27-Homologated-20-EPI-2-alkyl-19-NOR-vitamin D compounds
Grant 6,667,298 - DeLuca , et al. December 23, 2 | 2003-12-23 |
Use of vitamin d compounds to prevent transplants rejection
App 20030225045 - Deluca, Hector F. ; et al. | 2003-12-04 |
Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
App 20030207847 - DeLuca, Hector F. ; et al. | 2003-11-06 |
(20S) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
App 20030203882 - DeLuca, Hector F. ; et al. | 2003-10-30 |
2-Methylene-19-nor-20(S)-1alpha-hydroxy-bis-homo-pregnacalciferol in crystalline form
App 20030204103 - DeLuca, Hector F. ; et al. | 2003-10-30 |
Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
App 20030195175 - DeLuca, Hector F. ; et al. | 2003-10-16 |
Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalcife- rol
App 20030191095 - DeLuca, Hector F. ; et al. | 2003-10-09 |
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
Grant 6,627,622 - DeLuca , et al. September 30, 2 | 2003-09-30 |
1 .alpha.-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
Grant 6,566,352 - DeLuca , et al. May 20, 2 | 2003-05-20 |
26,27-Homologated-20-EPI-2-alklidene-19-nor-vitamin D compounds
Grant 6,537,981 - DeLuca , et al. March 25, 2 | 2003-03-25 |
Treatment of t-cell immunodeficiencies with vitamin D compounds
Grant 6,291,444 - DeLuca , et al. September 18, 2 | 2001-09-18 |
Use of vitamin D compounds to prevent transplant rejection
Grant 6,071,897 - DeLuca , et al. June 6, 2 | 2000-06-06 |
Animal feed containing carboxylic acids
Grant 6,022,555 - DeLuca , et al. February 8, 2 | 2000-02-08 |
2-alkyl-19-nor-vitamin D compounds
Grant 5,945,410 - DeLuca , et al. August 31, 1 | 1999-08-31 |
Low phosphorus animal feed containing 1.alpha.-hydroxylated vitamin D compounds and method of preparing
Grant 5,935,624 - DeLuca , et al. August 10, 1 | 1999-08-10 |
2-alkylidene-19-nor-vitamin D compounds
Grant 5,936,133 - Deluca , et al. August 10, 1 | 1999-08-10 |
Treatment of arthritic disease induced by infectious agents
Grant 5,891,865 - DeLuca , et al. April 6, 1 | 1999-04-06 |
Treatment of immune deficiency with vitamin D compounds
Grant 5,880,114 - Deluca , et al. March 9, 1 | 1999-03-09 |
All-trans-retinol metabolite
Grant 5,880,292 - DeLuca , et al. March 9, 1 | 1999-03-09 |
Preparation of 19-Nor-vitamin D compounds
Grant 5,856,536 - Deluca , et al. January 5, 1 | 1999-01-05 |
2-alkylidene-19-nor-vitamin D compounds
Grant 5,843,928 - Deluca , et al. December 1, 1 | 1998-12-01 |
18,19-dinor-vitamin D compounds
Grant 5,843,927 - DeLuca , et al. December 1, 1 | 1998-12-01 |
Homologated vitamin D2 compounds and the corresponding 1.alpha.-hydroxylated derivatives
Grant 5,750,746 - DeLuca , et al. May 12, 1 | 1998-05-12 |
19-Nor-vitamin D compounds
Grant 5,616,744 - DeLuca , et al. April 1, 1 | 1997-04-01 |
Prevention of hyperphosphatemia in kidney disorder patients
Grant 5,597,815 - Deluca , et al. January 28, 1 | 1997-01-28 |
(E)-20 (22)-dehydrodiels-alder compounds
Grant 5,536,828 - Deluca , et al. July 16, 1 | 1996-07-16 |
19-Nor-vitamin D.sub.3 compounds with substitutent at 2-position
Grant 5,536,713 - Deluca , et al. July 16, 1 | 1996-07-16 |
Synthesis of 19-nor vitamin D compounds
Grant 5,486,636 - DeLuca , et al. January 23, 1 | 1996-01-23 |
(E)-20(22)-dehydrovitamin D compounds
Grant 5,484,782 - DeLuca , et al. January 16, 1 | 1996-01-16 |
Methods using vitamin D compounds for improvement of skin conditions
Grant 5,459,136 - DeLuca , et al. October 17, 1 | 1995-10-17 |
| 